Production (Stage)
Antiaging Quantum Living Inc.
AAQL
$0.75
-$0.06-7.41%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 288.20K | 154.50K | 173.20K | 202.10K | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 288.20K | 154.50K | 173.20K | 202.10K | 0.00 |
| Cost of Revenue | 369.70K | 5.20K | 14.40K | 200.00 | 0.00 |
| Gross Profit | -81.50K | 149.30K | 158.80K | 201.90K | 0.00 |
| SG&A Expenses | 97.90K | 348.10K | 356.60K | 415.80K | 261.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 467.60K | 353.30K | 370.90K | 416.00K | 261.80K |
| Operating Income | -179.40K | -198.80K | -197.80K | -213.90K | -261.80K |
| Income Before Tax | -179.60K | -129.20K | -197.70K | -213.90K | -261.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -179.60K | -129.20K | -197.70K | -213.90K | -261.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -179.60K | -129.20K | -197.70K | -213.90K | -261.80K |
| EBIT | -179.40K | -198.80K | -197.80K | -213.90K | -261.80K |
| EBITDA | -143.40K | -162.60K | -146.30K | -193.50K | -255.10K |
| EPS Basic | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 30.00M | 30.00M | 30.00M | 29.96M | 30.00M |
| Average Diluted Shares Outstanding | 30.00M | 30.00M | 30.00M | 29.96M | 30.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |